Harvard bioscience, inc. reports earnings results for the third quarter ended september 30, 2019

Harvard bioscience, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced sales was usd 27.418 million compared to usd 28.635 million a year ago. operating loss was usd 1.365 million compared to operating income of usd 890,000 a year ago. net loss was usd 2.620 million compared to usd 256,000 a year ago. basic loss per share was usd 0.07 compared to usd 0.01 a year ago. for the nine months, sales was usd 85.204 million compared to usd 86.916 million a year ago. operating loss was usd 1.257 million compared to usd 758,000 a year ago. net loss was usd 5.237 million compared to usd 5.784 million a year ago. basic loss per share from continuing operations was usd 0.14 compared to usd 0.21 a year ago. basic loss per share was usd 0.14 compared to usd 0.16 a year ago.
HBIO Ratings Summary
HBIO Quant Ranking